tirzepatide addiction The latest AAAP podcast episode is live! 🎙️ Could medications like semaglutide and become a new tool in treating Alcohol Use Disorder? In this episode, hosts Danae DiRocco, MD, MPH and Anti-Consumption Agents: Tirzepatide and Semaglutide

No corticosteroids were administered

06/05/25 RxOutlook - 2nd Quarter 2025 01/17/25 Lumakras (sotorasib) plus Vectibix (panitumumab) New indication January 17, 2025 - Amgen announced the FDA approval of Lumakras (sotorasib), in combination with Vectibix (panitumumab), for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as determined by an FDA-approved test, who have received prior fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy

Lifestyle execution in the real world Semaglutide can make it easier to eat less, but it does not automatically guarantee a high-protein diet, adequate fibre intake, resistance training, and daily movement

The FDA boxed warning and contraindications for semaglutide apply at any dose (FDA Wegovy label)

Augmentin causes diarrhea in 10-15% of patients

The dual action of these medications makes them highly effective in controlling blood glucose levels while simultaneously promoting weight loss